ad image

Stem Cells

1 / 2
Resetting the Biological Clock: OKSM and the Reversal of Aging
Aging

Resetting the Biological Clock: OKSM and the Reversal of Aging

David Alvaro, Ph.D.

Pharma's Almanac

PAO-25-30-22Mar 19, 2025
NMDP
Clinical Trial Enrollment

NMDP Announces Enrollment of First Patient in OPTIMIZE Clinical Trial

NMDP

PR-M03-24-01Mar 05, 2024
Designing A Recipe for Stem Cell Therapy Success
Stem Cell Therapy

Designing A Recipe for Stem Cell Therapy Success

Ben Josey, Ph.D.; Robert Padilla

Corning Life Sciences

PTV-12-23-CL-01Dec 12, 2023
Taking a Page from the HSCT Playbook for Allogeneic Cell Therapy Advancement
Allogeneic Cell Therapy Logistics

Taking a Page from the HSCT Playbook for Allogeneic Cell Therapy Advancement

Joy Aho, Ph.D.

Be The Match BioTherapies

PAO-06-23-CL-06Jun 27, 2023
Pluristyx
Stem Cells

Pluristyx and Accelerated Biosciences Announce Availability of Clinical-Grade Immune-Privileged Human Trophoblast Stem Cells (hTSCs)

Pluristyx

PR-M04-22-15Apr 28, 2022
Delivering Pluripotent Stems Cells Primed to Differentiate
Stem Cells

Delivering Pluripotent Stems Cells Primed to Differentiate

Pluristyx

PAO-04-22-R250-71Apr 26, 2022
Moving Beyond the Industrialization of MSCs
Mesenchymal Stem Cells

Moving Beyond the Industrialization of MSCs

Tim Kelly, Ph.D.

RoosterBio

PAO-12-21-CL-06Mar 12, 2022
Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure
Cell Therapy

Enabling Novel Cell Therapies by Leveraging Established Blood Stem Cell Transplant Infrastructure

Chris McClain

Be The Match BioTherapies

PAO-09-21-CL-04Sep 09, 2021
Catalent

Catalent to Acquire RheinCell Therapeutics, Strengthening a Path Towards Industrialization of Induced Pluripotent Stem Cell-based Therapies

Catalent

PA909Jun 25, 2021
Curi Bio
Stem Cells

Curi Bio Raises $6M Series A Financing Round for iPSC-derived Predictive Platforms

Curi Bio

PR-M03-21-004-1062Mar 18, 2021
Changing the Paradigm of Stem Cell Technology
Stem Cells

Changing the Paradigm of Stem Cell Technology

Sandy Solmon

Celavie Biosciences

PAP-Q4-20-CL-008Dec 09, 2020
How Does Altis Biosystems Envision the Future of the Pharma/Biopharma Industry?
The Future of Healthcare

How Does Altis Biosystems Envision the Future of the Pharma/Biopharma Industry?

Altis Biosystems

PAP-Q4-20-RT2-015Dec 09, 2020
iPSCs: Moving from Drug Testing to Novel Cell Therapies
Stem Cells

iPSCs: Moving from Drug Testing to Novel Cell Therapies

Cenk Sumen, Ph.D.

MaxCyte

PAP-Q3-19-CL-030Oct 28, 2019
Viagra Helps Mobilize Bone Marrow Stem Cells for Transplantation in Mice
Research

Viagra Helps Mobilize Bone Marrow Stem Cells for Transplantation in Mice

Nice Insight

PR-M10-19-NI-018Oct 11, 2019
U.S. Food & Drug Administration
FDA Warning

FDA Sends Warning to Company for Selling Unapproved Umbilical Cord Products

U.S. Food & Drug Administration

PR-M09-19-NI-015Sep 06, 2019
Recovering from Cancer Treatment May Get Easier

Recovering from Cancer Treatment May Get Easier

Pharma's Almanac

PA2186Aug 27, 2019
Editing Adult Blood Stem Cells Could Treat Blood Disorders
CRISPR

Editing Adult Blood Stem Cells Could Treat Blood Disorders

Emilie Branch

Pharma's Almanac

PAO-M08-19-NI-029Aug 22, 2019
Exploring the Efficacy of Stem Cells in Reversing Age-Related Frailty
Stem Cell Therapy

Exploring the Efficacy of Stem Cells in Reversing Age-Related Frailty

Geoff Green

Longeveron

PAP-Q2-2019-CL-023May 24, 2019
Cold Spring Harbor Laboratory
Stem Cells

To Protect Stem Cells, Plants Have Diverse Genetic Backup Plans

Cold Spring Harbor Laboratory

PR-M04-19-NI-056Apr 17, 2019
U.S. Food & Drug Administration
Stem Cells

Statement by FDA on Efforts to Stop Stem Cell Clinics and Manufacturers from Marketing Unapproved Products and Advance Legitimate Development

U.S. Food & Drug Administration

PR-M04-19-NI-031Apr 09, 2019
1 / 2